These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28591590)

  • 1. Salt-regulated reversible fibrillation of Mycobacterium tuberculosis isocitrate lyase: Concurrent restoration of structure and activity.
    Shukla H; Kumar R; Sonkar A; Mitra K; Akhtar MS; Tripathi T
    Int J Biol Macromol; 2017 Nov; 104(Pt A):89-96. PubMed ID: 28591590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the structural flexibility and function of Mycobacterium tuberculosis isocitrate lyase.
    Shukla H; Kumar V; Singh AK; Singh N; Kashif M; Siddiqi MI; Yasoda Krishnan M; Sohail Akhtar M
    Biochimie; 2015 Mar; 110():73-80. PubMed ID: 25576828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
    Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
    J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis isocitrate lyase (MtbIcl): role of divalent cations in modulation of functional and structural properties.
    Kumar R; Bhakuni V
    Proteins; 2008 Aug; 72(3):892-900. PubMed ID: 18275086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus.
    Shukla H; Kumar V; Singh AK; Rastogi S; Khan SR; Siddiqi MI; Krishnan MY; Akhtar MS
    Int J Biol Macromol; 2015; 78():137-41. PubMed ID: 25869309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine succinylation of Mycobacterium tuberculosis isocitrate lyase (ICL) fine-tunes the microbial resistance to antibiotics.
    Zhou M; Xie L; Yang Z; Zhou J; Xie J
    J Biomol Struct Dyn; 2017 Apr; 35(5):1030-1041. PubMed ID: 27023679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility.
    Shukla H; Shukla R; Sonkar A; Pandey T; Tripathi T
    Sci Rep; 2017 Apr; 7(1):1058. PubMed ID: 28432345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active Site Flexibility of Mycobacterium tuberculosis Isocitrate Lyase in Dimer Form.
    Lee YV; Choi SB; Wahab HA; Choong YS
    J Chem Inf Model; 2017 Sep; 57(9):2351-2357. PubMed ID: 28820943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural plasticity and collective motions of the active site.
    Shukla R; Shukla H; Tripathi T
    Tuberculosis (Edinb); 2018 Jan; 108():143-150. PubMed ID: 29523315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis.
    Höner Zu Bentrup K; Miczak A; Swenson DL; Russell DG
    J Bacteriol; 1999 Dec; 181(23):7161-7. PubMed ID: 10572116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternate pathway to ascorbate induced inhibition of Mycobacterium tuberculosis.
    Shukla H; Khan SR; Shukla R; Krishnan MY; Akhtar MS; Tripathi T
    Tuberculosis (Edinb); 2018 Jul; 111():161-169. PubMed ID: 30029903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in conformational topology and interaction dynamics caused by L418A mutation leads to activity loss of Mycobacterium tuberculosis isocitrate lyase.
    Shukla H; Shukla R; Sonkar A; Tripathi T
    Biochem Biophys Res Commun; 2017 Aug; 490(2):276-282. PubMed ID: 28610921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Anti-mycobacterial Phytochemical Compounds for Potential Inhibitors against Mycobacterium Tuberculosis Isocitrate Lyase.
    Tiwari A; Kumar A; Srivastava G; Sharma A
    Curr Top Med Chem; 2019; 19(8):600-608. PubMed ID: 30836915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.
    Sharma V; Sharma S; Hoener zu Bentrup K; McKinney JD; Russell DG; Jacobs WR; Sacchettini JC
    Nat Struct Biol; 2000 Aug; 7(8):663-8. PubMed ID: 10932251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2.
    Bhusal RP; Jiao W; Kwai BXC; Reynisson J; Collins AJ; Sperry J; Bashiri G; Leung IKH
    Nat Commun; 2019 Oct; 10(1):4639. PubMed ID: 31604954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function insights into elusive Mycobacterium tuberculosis protein Rv1916.
    Antil M; Sharma J; Brissonnet Y; Choudhary M; Gouin S; Gupta V
    Int J Biol Macromol; 2019 Dec; 141():927-936. PubMed ID: 31505209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary.
    Lee YV; Wahab HA; Choong YS
    Biomed Res Int; 2015; 2015():895453. PubMed ID: 25649791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase.
    Ibeji CU; Salleh NAM; Sum JS; Ch'ng ACW; Lim TS; Choong YS
    Sci Rep; 2020 Nov; 10(1):18925. PubMed ID: 33144641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence.
    Muñoz-Elías EJ; McKinney JD
    Nat Med; 2005 Jun; 11(6):638-44. PubMed ID: 15895072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.